NCT04873349View on ClinicalTrials.gov

Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

August 1, 2022

Conditions
Covid19COVID-19 Respiratory InfectionSymptoms and SignsCOVID-19 Acute BronchitisDisseminated Intravascular Coagulation
Interventions
DIETARY_SUPPLEMENT

Nusapure standardized olive leaves capsule, 750 mg (50% oleuropein)

two study groups; test group will receive Nusapure standardized olive leaves capsule, 750 mg (50% oleuropein) while placebo group will receive starch group

Trial Locations (1)

63514

Shimaa Abdelgawad, Al Fayyum

All Listed Sponsors
lead

Shimaa M. Abdelgawad

OTHER